top of page

Vitiligo: Chapter 2

Written by: Lucky Annem

Medically reviewed by: Dr. Lohi Pratti


Vitiligo is a skin condition characterized by patches of the skin losing pigmentation. It occurs when the melanocytes, the cells responsible for producing melanin, the pigment that gives color to the skin, hair, and eyes, are destroyed. The exact cause of vitiligo is not known, but it is thought to be due to genetic predisposition and problems with the immune system. It can affect people of any age, race, or gender. There is no cure for vitiligo, but treatments include medical options like topical creams, light therapy, and skin grafting, as well as cosmetic camouflage. The genetic component of vitiligo is not well understood, but several studies suggest that there may be a hereditary factor involved in the development of the condition. Family studies have shown that there is a higher incidence of vitiligo in families with a history of the disease, suggesting that there may be a genetic predisposition to the condition. Additionally, genetic studies have identified several genes that appear to be associated with an increased risk of developing vitiligo. These genes include those involved in the regulation of melanin production, the immune system, and oxidative stress. It's important to note that while genetics may play a role in the development of vitiligo, it is not the only factor involved. Vitiligo can be caused or made worse by environmental stressors, especially chemical phenols that appear like the amino acid tyrosine and the products that contain them. Other factors, such as other autoimmune disorders and physical injury, can also contribute to the development of the condition. The exact cause of vitiligo is still not fully understood and requires further research to fully understand the genetic and environmental factors involved.


Topical corticosteroid creams are a type of medication commonly used to treat vitiligo. They work by reducing inflammation and suppressing the immune system, which can help to slow down the loss of pigment in affected skin. Topical corticosteroids are applied directly to the affected skin, usually once or twice a day. The strength of the steroid used will depend on the severity of the vitiligo, as well as other factors such as the patient's age, health, and overall skin condition. It's important to note that while topical corticosteroids can be effective in treating vitiligo, they should only be used under medical supervision. Long-term use of high-potency steroids can lead to skin thinning, stretch marks, and more. Apart from local skin side effects, when used for longer times, corticosteroids can get absorbed into the blood and have systematic implications. Additionally, topical corticosteroids are not effective in all cases and may not produce significant results in all patients. Other treatments, such as light therapy or skin grafting, may be necessary in combination with or as an alternative to topical corticosteroids to achieve the desired results. Studies have shown that children respond better to treatments with tacrolimus, which is a steroid sparing agent. Interestingly, sun exposed areas in the body respond better to treatment while finger tip lesions show poor response. Ultimately, the best treatment approach will depend on the individual case and should be determined by a qualified healthcare provider.


Psoralen plus ultraviolet A (PUVA) therapy is a type of light therapy used to treat vitiligo. It involves the oral or topical administration of psoralen, a photosensitizing drug, followed by exposure to ultraviolet A (UVA) light. The psoralen makes the skin more sensitive to light, and when combined with UVA light, it can stimulate the production of melanin and help to repigment the affected skin. PUVA therapy is usually performed two to three times per week and can take several months to produce noticeable results. PUVA therapy is generally considered safe, but it can cause side effects, such as itching, redness, and blistering of the skin. Long-term exposure to UVA light can also increase the risk of skin aging and skin cancer. It's important to note that PUVA therapy is not effective in all cases and may not produce significant results in all patients. Additionally, the results of PUVA therapy are not permanent and the affected skin may return to its original color over time. The best treatment approach will depend on the individual case and should be determined by a qualified healthcare provider.


Narrowband ultraviolet B (NB-UVB) therapy is a type of light therapy used to treat vitiligo. It involves exposing the affected skin to a specific type of ultraviolet B (UVB) light. NB-UVB therapy works by stimulating the production of melanin and restoring color to the affected skin. It is typically performed two to three times per week, and treatment sessions can last anywhere from a few seconds to several minutes, depending on the severity of the vitiligo. NB-UVB therapy is generally considered safe and has fewer side effects compared to other light therapies, such as PUVA therapy. However, like all light therapies, it does increase the risk of skin aging and skin cancer with long-term use. It's important to note that NB-UVB therapy is not effective in all cases and may not produce significant results in all patients. A study found that repigmentation happened faster and better when NB-UVB and tacrolimus 0.1% were used together than when NB-UVB was used alone. The best treatment approach will depend on the individual case and should be determined by a qualified healthcare provider.


Winnie Harlow is a Canadian model, actress, and public speaker who rose to prominence after competing in the 21st cycle of America's Next Top Model. She was diagnosed with vitiligo, a skin condition characterized by loss of pigmentation, at a young age, and her unique appearance has since made her one of the most recognizable faces in the fashion industry. Harlow has used her platform to raise awareness about vitiligo and to promote body positivity and self-acceptance. She has walked in numerous high-profile fashion shows, including Victoria's Secret, and has appeared in campaigns for brands such as Diesel and Swarovski. In addition to her modeling work, Harlow has also been a public speaker, using her experiences to encourage others to embrace their individuality and challenge conventional beauty standards. Her success in the fashion industry has also helped to bring attention to the issue of vitiligo and has inspired others with the condition to feel proud of their appearance. Through her work, Harlow has become a role model for people with vitiligo and a symbol of the beauty of diversity.


Body acceptance for people with vitiligo can be a challenge, as societal standards of beauty often emphasize uniform skin tone and can lead to discrimination and marginalization for those with differently pigmented skin. However, individuals with vitiligo are increasingly advocating for body positivity and acceptance, and the fashion and beauty industries have begun to embrace diversity and individuality in recent years. There has been a growing movement to celebrate and promote the beauty of all skin tones, including those with vitiligo. People with vitiligo can benefit from supportive communities and resources, such as online forums and social media groups, that provide a space to share experiences and connect with others who understand the unique challenges they face. Additionally, organizations that work to raise awareness about vitiligo and promote body positivity can also provide valuable resources and support. Ultimately, body acceptance for people with vitiligo starts with embracing and celebrating one's individuality. This can be a journey, but with time, self-care, and supportive communities, individuals with vitiligo can develop a positive relationship with their bodies and feel confident and proud of who they are.



References:

“Winnie Harlow Shared What It’s like Living with Vitiligo.” Health, 2018, www.health.com/condition/vitiligo/winnie-harlow-vitiligo-vs-fashion-show.


Dillon, A.B., Sideris, A., Hadi, A., Elbuluk, N., 2017. Advances in Vitiligo: An Update on

Medical and Surgical Treatments. J. Clin. Aesthetic Dermatol. 10, 15.


Kubelis-López, D.E., Zapata-Salazar, N.A., Said-Fernández, S.L., Sánchez-Domínguez, C.N., Salinas-Santander, M.A., Martínez-Rodríguez, H.G., Vázquez-Martínez, O.T., Wollina, U., Lotti, T., Ocampo-Candiani, J., 2021. Updates and new medical treatments for vitiligo (Review). Exp. Ther. Med. 22. https://doi.org/10.3892/etm.2021.10229


Myers, Elisha, et al. “An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases.” Cureus, Nov. 2021, https://doi.org/10.7759/cureus.19182. Accessed 31 Jan. 2023.


“Narrowband UVB Phototherapy | DermNet.” Dermnetnz.org, 2022, dermnetnz.org/topics/narrowband-uvb-phototherapy. Accessed 31 Jan. 2023.


NIAMS. “Vitiligo.” National Institute of Arthritis and Musculoskeletal and Skin Diseases, 12 Apr. 2017, www.niams.nih.gov/health-topics/vitiligo.


Rashighi, M., Harris, J.E., 2017. Vitiligo pathogenesis and emerging treatments. Dermatol.

Clin. 35, 257–265. https://doi.org/10.1016/j.det.2016.11.014


“St. Luke’s - Psoralen plus Ultraviolet Light Therapy PUVA for Atopic Dermatitis.” Stlukesonline.org, 2015, www.stlukesonline.org/health-services/health-information/healthwise/2015/05/15/13/54/psoralen-plus-ultraviolet-light-therapy-puva-for-atopic-dermatitis.


“UpToDate.” Uptodate.com, 2023, www.uptodate.com/contents/psoralen-plus-ultraviolet-a-puva-photochemotherapy.


“Vitiligo Made Me Famous, but It’s Not Who I Am.” Cosmopolitan, 13 July 2022, www.cosmopolitan.com/style-beauty/beauty/a40458553/winnie-harlow-vitiligo-skincare/.


“Vitiligo: Overview.” Aad.org, 2016, www.aad.org/public/diseases/a-z/vitiligo-overview.


“Vitiligo - Symptoms and Causes.” Mayo Clinic, 2022, www.mayoclinic.org/diseases-conditions/vitiligo/symptoms-causes/syc20355912#:~:text=Vitiligo%20(vit%2Dih%2DLIE,skin%20is%20determined%20by%20melanin.


“Vitiligo: Types, Symptoms, Causes, Treatment & Recovery.” Cleveland Clinic, 2022, my.clevelandclinic.org/health/diseases/12419-vitiligo.


Disclaimer: This organization's content is not intended to provide diagnosis, treatment, or medical advice. Content provided on this website is for informational and educational purposes only. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options. Information on this website should not be considered as a substitute for advice from a healthcare professional.

Comments


bottom of page